Alexandre Walencik

600 total citations
40 papers, 230 citations indexed

About

Alexandre Walencik is a scholar working on Immunology, Epidemiology and Transplantation. According to data from OpenAlex, Alexandre Walencik has authored 40 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 6 papers in Epidemiology and 6 papers in Transplantation. Recurrent topics in Alexandre Walencik's work include T-cell and B-cell Immunology (32 papers), Immune Cell Function and Interaction (28 papers) and Immunotherapy and Immune Responses (23 papers). Alexandre Walencik is often cited by papers focused on T-cell and B-cell Immunology (32 papers), Immune Cell Function and Interaction (28 papers) and Immunotherapy and Immune Responses (23 papers). Alexandre Walencik collaborates with scholars based in France, United States and United Kingdom. Alexandre Walencik's co-authors include Marie‐Christine Jacob, Fabienne Venet, Alain Lepape, Jean‐François Timsit, Guillaume Monneret, Julie Demaret, Coralie Frassati, Mehdi Alizadeh, Françoise Bonneville and G. Sémana and has published in prestigious journals such as Bioinformatics, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Alexandre Walencik

39 papers receiving 226 citations

Peers

Alexandre Walencik
Alexandre Walencik
Citations per year, relative to Alexandre Walencik Alexandre Walencik (= 1×) peers Aurélie Duthey

Countries citing papers authored by Alexandre Walencik

Since Specialization
Citations

This map shows the geographic impact of Alexandre Walencik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Walencik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Walencik more than expected).

Fields of papers citing papers by Alexandre Walencik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Walencik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Walencik. The network helps show where Alexandre Walencik may publish in the future.

Co-authorship network of co-authors of Alexandre Walencik

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Walencik. A scholar is included among the top collaborators of Alexandre Walencik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Walencik. Alexandre Walencik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
David, Gaëlle, Cynthia Fourgeux, Catherine Willem, et al.. (2025). Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell Responses. Journal of Clinical Immunology. 45(1). 118–118. 1 indexed citations
2.
Gatouillat, Grégory, et al.. (2024). Characterisation of the novel HLA‐DQA1*04:14N allele by next‐generation sequencing. HLA. 103(6). e15571–e15571. 1 indexed citations
3.
David, Gaëlle, Catherine Willem, Nolwenn Legrand, et al.. (2024). Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence. Frontiers in Immunology. 15. 1389358–1389358. 3 indexed citations
4.
Walencik, Alexandre, et al.. (2023). Characterization of the novel HLA‐A*33:246 allele using next‐generation sequencing. HLA. 102(5). 617–619. 2 indexed citations
5.
Le, Hoa, Nicolas Degauque, Marie Rimbert, et al.. (2023). Kidney allograft rejection is associated with an imbalance of B cells, regulatory T cells and differentiated CD28-CD8+ T cells: analysis of a cohort of 1095 graft biopsies. Frontiers in Immunology. 14. 1151127–1151127. 9 indexed citations
6.
Gatouillat, Grégory, et al.. (2023). Characterization of the novel HLA‐B*15:648 allele by next‐generation sequencing. HLA. 103(1). e15323–e15323. 2 indexed citations
7.
Masset, Christophe, Clarisse Kerleau, Gilles Blancho, et al.. (2023). Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients. Transplant International. 36. 10816–10816. 4 indexed citations
8.
9.
Masset, Christophe, Gabriela Gautier-Vargas, Diego Cantarovich, et al.. (2022). Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation. Kidney International Reports. 7(5). 983–992. 10 indexed citations
10.
Masset, Christophe, Jacques Dantal, Jean‐Paul Soulillou, et al.. (2022). Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patients. Frontiers in Immunology. 13. 1021481–1021481. 3 indexed citations
11.
Dard, Céline, Christophe Picard, B. Proust, et al.. (2021). Biobanking in a histocompatibility laboratory. Guidelines from the Francophone Society of Histocompatibility and Immunogenetics (SFHI). Annales de biologie clinique. 79(4). 371–378.
12.
Walencik, Alexandre, et al.. (2021). Characterization of the novel HLA‐A*23:118 allele by two next‐generation sequencing methods. HLA. 99(3). 197–198. 1 indexed citations
13.
David, Gaëlle, Catherine Willem, Nolwenn Legrand, et al.. (2021). Deciphering the biology of KIR2DL3+ T lymphocytes that are associated to relapse in haploidentical HSCT. Scientific Reports. 11(1). 15782–15782. 3 indexed citations
14.
Walencik, Alexandre, Karine Laulagnier, Jean‐Paul Molens, et al.. (2021). Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells. Vaccines. 9(2). 141–141. 6 indexed citations
15.
David, Gaëlle, Nolwenn Legrand, Catherine Willem, et al.. (2021). Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response. OncoImmunology. 10(1). 1936392–1936392. 13 indexed citations
16.
Walencik, Alexandre, et al.. (2021). Characterization of the novel HLA‐C*07:01:105 allele by two next‐generation sequencing methods. HLA. 99(3). 218–219. 1 indexed citations
17.
Alizadeh, Mehdi, Christine J. Picard, Coralie Frassati, et al.. (2020). A new set of reagents and related software used for NGS based classical and non-classical HLA typing showing evidence for a greater HLA haplotype diversity. Human Immunology. 81(5). 202–205. 25 indexed citations
18.
Legrand, Nolwenn, Catherine Willem, Gaëlle David, et al.. (2017). Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing Technology. Frontiers in Immunology. 8. 547–547. 19 indexed citations
19.
Alizadeh, Mehdi, et al.. (2017). Evidence for a higher resolution of HLA genotyping by a new NGS-based approach. Transfusion Clinique et Biologique. 24(3). 120–123. 7 indexed citations
20.
Demaret, Julie, Alexandre Walencik, Marie‐Christine Jacob, et al.. (2012). Inter‐laboratory assessment of flow cytometric monocyte HLA‐DR expression in clinical samples. Cytometry Part B Clinical Cytometry. 84B(1). 59–62. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026